These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 38638307)

  • 1. Long COVID and its association with neurodegenerative diseases: pathogenesis, neuroimaging, and treatment.
    Zhao J; Xia F; Jiao X; Lyu X
    Front Neurol; 2024; 15():1367974. PubMed ID: 38638307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
    Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
    Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-Analysis of the Mechanisms Underlying COVID-19 Modulation of Parkinson's Disease.
    Zhang J; Bishir M; Barbhuiya S; Chang SL
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and neurodegenerative diseases.
    Fu YW; Xu HS; Liu SJ
    Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4535-4544. PubMed ID: 35776055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putative mechanism of neurological damage in COVID-19 infection.
    Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-Rodríguez A
    Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?
    Serrano-Castro PJ; Estivill-Torrús G; Cabezudo-García P; Reyes-Bueno JA; Ciano Petersen N; Aguilar-Castillo MJ; Suárez-Pérez J; Jiménez-Hernández MD; Moya-Molina MÁ; Oliver-Martos B; Arrabal-Gómez C; Rodríguez de Fonseca F
    Neurologia (Engl Ed); 2020 May; 35(4):245-251. PubMed ID: 32364119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Infection to Premature Neuronal Aging and Neurodegenerative Diseases: Is there any Connection with Hypoxia?
    Sivagurunathan N; Calivarathan L
    CNS Neurol Disord Drug Targets; 2024; 23(4):431-448. PubMed ID: 37073650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 mediated neurological disorders in COVID-19: Measuring the pathophysiology and immune response.
    Hsu PC; Shahed-Al-Mahmud M
    Life Sci; 2022 Nov; 308():120981. PubMed ID: 36150465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson's Disease: A Narrative Review.
    Morowitz JM; Pogson KB; Roque DA; Church FC
    Brain Sci; 2022 Apr; 12(5):. PubMed ID: 35624923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.
    Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manifestations and mechanisms of central nervous system damage caused by SARS-CoV-2.
    Yang F; Zhao H; Liu H; Wu X; Li Y
    Brain Res Bull; 2021 Dec; 177():155-163. PubMed ID: 34571039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-COVID-19 Parkinsonism and Parkinson's Disease Pathogenesis: The Exosomal Cargo Hypothesis.
    Mysiris DS; Vavougios GD; Karamichali E; Papoutsopoulou S; Stavrou VT; Papayianni E; Boutlas S; Mavridis T; Foka P; Zarogiannis SG; Gourgoulianis K; Xiromerisiou G
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
    Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F
    Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports.
    Najjar S; Najjar A; Chong DJ; Pramanik BK; Kirsch C; Kuzniecky RI; Pacia SV; Azhar S
    J Neuroinflammation; 2020 Aug; 17(1):231. PubMed ID: 32758257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia.
    Barbieri MA; Bagnato G; Ioppolo C; Versace AG; Irrera N
    CNS Neurol Disord Drug Targets; 2022; 21(10):1017-1026. PubMed ID: 35021982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global Consortium.
    de Erausquin GA; Snyder H; Brugha TS; Seshadri S; Carrillo M; Sagar R; Huang Y; Newton C; Tartaglia C; Teunissen C; Håkanson K; Akinyemi R; Prasad K; D'Avossa G; Gonzalez-Aleman G; Hosseini A; Vavougios GD; Sachdev P; Bankart J; Mors NPO; Lipton R; Katz M; Fox PT; Katshu MZ; Iyengar MS; Weinstein G; Sohrabi HR; Jenkins R; Stein DJ; Hugon J; Mavreas V; Blangero J; Cruchaga C; Krishna M; Wadoo O; Becerra R; Zwir I; Longstreth WT; Kroenenberg G; Edison P; Mukaetova-Ladinska E; Staufenberg E; Figueredo-Aguiar M; Yécora A; Vaca F; Zamponi HP; Re VL; Majid A; Sundarakumar J; Gonzalez HM; Geerlings MI; Skoog I; Salmoiraghi A; Boneschi FM; Patel VN; Santos JM; Arroyo GR; Moreno AC; Felix P; Gallo C; Arai H; Yamada M; Iwatsubo T; Sharma M; Chakraborty N; Ferreccio C; Akena D; Brayne C; Maestre G; Blangero SW; Brusco LI; Siddarth P; Hughes TM; Zuñiga AR; Kambeitz J; Laza AR; Allen N; Panos S; Merrill D; Ibáñez A; Tsuang D; Valishvili N; Shrestha S; Wang S; Padma V; Anstey KJ; Ravindrdanath V; Blennow K; Mullins P; Łojek E; Pria A; Mosley TH; Gowland P; Girard TD; Bowtell R; Vahidy FS
    Alzheimers Dement (N Y); 2022; 8(1):e12348. PubMed ID: 36185993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic dysfunction in COVID-19: frantic search and hoping for the best.
    Nadwa EH; Al-Kuraishy HM; Al-Gareeb AI; Elekhnawy E; Albogami SM; Alorabi M; Batiha GE; De Waard M
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Mar; 396(3):453-468. PubMed ID: 36460816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOX2 Activation in COVID-19: Possible Implications for Neurodegenerative Diseases.
    Sindona C; Schepici G; Contestabile V; Bramanti P; Mazzon E
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34208136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of System Biology to Explore the Association of Neprilysin, Angiotensin-Converting Enzyme 2 (ACE2), and Carbonic Anhydrase (CA) in Pathogenesis of SARS-CoV-2.
    Zolfaghari Emameh R; Falak R; Bahreini E
    Biol Proced Online; 2020; 22():11. PubMed ID: 32572334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
    Murta V; Villarreal A; Ramos AJ
    ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.